|
Roger Perlmutter, M.D., Ph.D., is Executive Vice President of Research and Development at Amgen, Inc., a position he assumed in January 2001. He was formerly Executive Vice President, Worldwide Basic Research and Preclinical Development for Merck Research Laboratories. Dr. Perlmutter joined Merck as Senior Vice President, Merck Research Laboratories in February 1997 and was named Executive Vice President in 1999. Prior to joining Merck, Dr. Perlmutter was Chairman of the Department of Immunology and Professor of Immunology, Biochemistry and Medicine at the University of Washington. He previously held academic and clinical appointments at the California Institute of Technology and other academic institutions. Dr. Perlmutter was a Howard Hughes investigator earlier in his career and is one of the world's foremost authorities on immunology.
| 